6Pan XR, LI GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing ITG and Diabetes Study. Diabetes Care, 1997, 20 (3) : 537.
7Bantle JP, Swanson JE, Thomas W, et al. Metabolic effect of dietary sucrose in type 2 diabetes subjects. Diabetes Care, 1993, 16 (8):1301.
5American Diabetes Association. Standards of medical care in diabetes [ J ]. Diabetes care, 2004, 27 (Suppl 1): S15-35.
6UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or in- sulin compared with conventional treatment and risk of complications in patients with type 2 diabetes ( UKPDS 33) [J]. Lancet, 1998, 352 (9131): 837-853.
7Davidon J, Koro C, Arondekar B, et al. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients[ J]. Clin Ther, 2008, 30:287 -293.
8Monnier L, Lapinski H, Colette C, et al. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetes patients [ J]. Diabetes Care, 2003, 26 (3) :881 -885.
9Woerle H J, Neumann C, Zschau S, et al. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes importance of postprandial glycemia to achieve target HbAlc levels [ J ]. Diabetes Res Clin Pract, 2007, 77 (2): 280-285.
10Basyer E J 3rd, Stuart CA, Brodows RG, et al. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowing HbAlc[ J]. Diabetes Care, 2000. 23 (9) : 1236 -1241.
